Considering Clinical Trials: An MPN Expert Explains Why Treatment Options Matter With Myelofibrosis
Topic Areas:
Myeloproliferative Neoplasms
View next
Published on August 2, 2017
Dr. Catriona Jamieson, from Moores Cancer Center at UC San Diego Health, joined Patient Power to discuss considerations when choosing to participate in a clinical trial. Dr. Jamieson sheds light on the necessity of ongoing MPN clinical trials, particularly for myelofibrosis, as well as how to talk to your doctor about this treatment option.
